Karen Linehan

Karen Linehan

Director/Board Member at AELIS FARMA

Net worth: 226 356 $ as of 31/05/2026

67 year
Health Technology
Consumer Services
Communications

Profile

Karen Linehan currently works at CNH Industrial NV, as Independent Non-Executive Director from 2022, Global Antibiotic Research & Development Partnership, as Non-Executive Director, Aelis Farma SA, as Independent Director from 2022, Sanofi-Aventis Deutschland GmbH, as Member-Supervisory Board, Hoechst GmbH, as Member-Supervisory Board, and Georgetown University Law Center, as Member-Visitors Board.
Ms. Linehan also formerly worked at VEON Ltd., as Independent Non-Executive Director from 2022 to 2024, Sanofi, as Executive VP-Legal Affairs & General Counsel from 2014 to 2021, Townley & Updike, as Associate from 1986 to 1990, and EUROAPI SA, as Member-Supervisory Board.
Ms. Linehan received her undergraduate degree and graduate degree from Georgetown University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
26/05/2026 22,170 ( 0% ) 226 356 $ 31/05/2026

Karen Linehan active positions

CompaniesPositionStart
AELIS FARMA Director/Board Member 01/01/2022
CNH INDUSTRIAL N.V. Director/Board Member 11/03/2022
Director/Board Member -
Director/Board Member -
Director/Board Member -
Corporate Officer/Principal -

Former positions of Karen Linehan

CompaniesPositionEnd
VEON LTD. Director/Board Member 31/05/2024
SANOFI General Counsel 31/12/2021
EUROAPI Director/Board Member -
See the detail of Karen Linehan's experience

Training of Karen Linehan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

73

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Consumer Services

Health Technology

Communications

Health Technology

Producer Manufacturing

Consumer Services

Health Technology

Health Technology

Health Technology